Novel Gene Therapy Treatment for Head and Neck Cancer with Impressive Phase III Results in China
Sage's very exciting Chinese client, Guangzhou Doublle Bio-Product Co., Ltd., will report the results of its Chinese Phase 3 study of its...
top of page
Sage Group News
bottom of page